Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes [Phase 2, Phase 3]
A completed Phase 2/3 trial evaluating vildagliptin as add-on therapy to metformin for type 2 diabetes, reporting on efficacy and long-term …
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol? [Phase 4]
Phase 4 trial updating whether cilostazol can reduce ischemic events in diabetic artery obstruction-related conditions (ischemic stroke and …
-
CLINICAL_TRIALS trial_result · 2020-12-28Clinical Trial Update: Development of Diabetes Mobile Application [Phase 3]
Clinical trial update for a Phase 3 study on a diabetes mobile application targeting Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: Colesevelam for Children With Type 2 Diabetes [Phase 4]
Phase 4 trial investigating colesevelam in children with type 2 diabetes has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing fixed combination of vildagliptin and metformin versus individual components in drug-naive type 2 diabetes patients …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%) [Phase 3]
Phase 3 trial evaluating fixed-dose combination therapy of vildagliptin and metformin in type 2 diabetes inadequately controlled on metformi…
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: A Sub-study to LMF237A2302 to Assess the Effect of 24 Weeks Treatment With Initial Combination of Vildagliptin Plus Metformin [Phase 3]
A Phase 3 sub-study evaluating 24 weeks of initial combination therapy with vildagliptin plus metformin in adults with Type 2 diabetes melli…
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: DPP4 Inhibitor on Glycemic Variability [Phase 4]
A Phase 4 clinical trial evaluating a DPP4 inhibitor's effect on glycemic variability in type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM) [Phase 1, Phase 2]
Clinical trial update assessing safety, tolerability, PK and PD of LIK066 in healthy subjects and patients with type 2 diabetes mellitus acr…
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Drug Interaction of Vildagliptin (LAF237) With Voglibose in Japanese Patients With Type 2 Diabetes [Phase 4]
Phase 4 clinical trial investigating drug interaction between vildagliptin (LAF237) and voglibose in Japanese patients with Type 2 Diabetes.
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: A Clinical Study to Assess the Effect of Vildagliptin on Beta Cell Function in Drug Naive Patients With Type 2 Diabetes [Phase 3]
A Phase 3 clinical trial assessing the effect of vildagliptin on beta cell function in drug-naive patients with type 2 diabetes has complete…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin Alone [Phase 3]
Phase 3 trial update evaluating the efficacy and safety of a vildagliptin and metformin combination in adults with type 2 diabetes not adequ…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial comparing vildagliptin to metformin in elderly, drug-naive patients with type 2 diabetes completed.
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension) [Phase 3]
Phase 3 extension trial evaluating safety and tolerability of vildagliptin versus placebo in type 2 diabetes patients with moderate to sever…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes [Phase 2, Phase 3]
Clinical trial update reports efficacy and long-term safety data for vildagliptin as monotherapy in type 2 diabetes across Phase 2 and Phase…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency [Phase 3]
Phase 3 clinical trial evaluating the safety and tolerability of vildagliptin versus placebo in patients with type 2 diabetes and moderate t…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing vildagliptin to glimepiride as add-on to metformin in type 2 diabetes; completed.
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study) [Phase 3]
Phase 3 extension study comparing safety and tolerability of vildagliptin versus sitagliptin in type 2 diabetes patients with severe renal i…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes [Phase 3]
Phase 3 trial assessing efficacy and safety of vildagliptin combined with pioglitazone in adults with type 2 diabetes; study completed.
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing vildagliptin to gliclazide in combination with metformin for type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763 [Phase 1, Phase 2]
Phase 1/2 trial update on LEZ763 evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics.
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency [Phase 3]
Phase 3 trial comparing safety and tolerability of vildagliptin versus sitagliptin in type 2 diabetes patients with severe renal insufficien…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure [Phase 4]
A Phase 4 trial evaluating the effect of vildagliptin on left ventricular function in patients with type 2 diabetes and congestive heart fai…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Long-term Safety Study of Vildagliptin in Patients With Type 2 Diabetes [Phase 3]
Long-term safety study of vildagliptin in patients with type 2 diabetes has completed Phase 3 trial.
-
CLINICAL_TRIALS trial_result · 2020-12-16Clinical Trial Update: Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083) [Phase 3]
A Phase 3 trial evaluating sitagliptin as initial oral therapy for pediatric type 2 diabetes has completed with results posted.